Active ingredients in Chinese medicines promoting blood circulation as Na+ /K+-ATPase inhibitors

Acta Pharmacologica Sinica

Volumn 32, Issue 2, 2011, Pages 141-151

  Chen, Ronald J Y ^a   Jinn, Tzyy Rong ^b   Chen, Yi Ching ^a   Chung, Tse Yu ^a   Yang, Wei Hung ^a,b   Tzen, Jason T C ^a,b,c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

Author keywords

blood circulation; cardiac glycoside; ginsenoside; magnesium lithospermate B; Na+ K+ ATPase inhibitors; neuroprotection; steroid like compound; traditional Chinese medicine

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ASTRAGALOSIDE III; BETA BOSWELLIC ACID; BETULIC ACID; BUFALIN; CARDIAC GLYCOSIDE; CHOLIC ACID; CUCURBITACIN GLYCOSIDE; DEHYDROCORYDALINE; DIGOXIN; GINSENOSIDE; GINSENOSIDE RH 2; GLYCYRRHIZIC ACID; HIRSUTINE; INOKOSTERONE; ISOLIMONOIC ACID; JUJUBOSIDE B; MAGNESIUM LITHOSPERMATE; OLEANOLIC ACID; OUABAIN; PACHYMIC ACID; POLYGALACIC ACID; RHYNCHOPHYLLINE; SAIKOSAPONIN A; SAPONIN; SARSASAPOGENIN; SITOSTEROL; STEROID; TRITERPENOID; UNCLASSIFIED DRUG; URSOLIC ACID;

BRAIN ISCHEMIA; CHINESE MEDICINE; CIRCULATION; CONGESTIVE HEART FAILURE; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; GINSENG; HEART ARRHYTHMIA; HUMAN; HYDROGEN BOND; MEDICINAL PLANT; NEUROPROTECTION; NONHUMAN; REVIEW; SALVIA MILTIORRHIZA; STEREOSPECIFICITY;

ANIMALS; BLOOD CIRCULATION; CARDIAC GLYCOSIDES; DRUGS, CHINESE HERBAL; HUMANS; HYDROGEN BONDING; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, THEORETICAL; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 79551656119     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.197     Document Type: Review

References (100)

1. Boxer R, Yang SX, Hager WD. Congestive heart failure and the elderly. Conn Med 2003; 67: 497-503.
2. Haustein KO. Cardiotoxicity of digitalis. Arch Toxicol Suppl 1986; 9: 197-204.
3. Koren G, Woodland C, Ito S. Toxic digoxin-drug interactions: the major role of renal P-glycoprotein. Vet Hum Toxicol 1998; 40: 45-6.
4. Vivo RP, Krim SR, Perez J, Inklab M, Tenner T Jr, Hodgson J. Digoxin: current use and approach to toxicity. Am J Med Sci 2008; 336: 423-8.
5. Gong X, Sucher NJ. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development. Phytomedicine 2002; 9: 478-84.
6. Liang H, Chen S, Shen S. Clinical observation on influence of Chinese medicines for promoting blood circulation to remove blood stasis on FIB and DD in plasma of patients with cerebral thrombosis. J Tradit Chin Med 2002; 22: 256-9.
7. Yang M, Sun J, Lu Z, Chen G, Guan S, Liu X, et al. Phytochemical analysis of traditional Chinese medicine using liquid chromatography coupled with mass spectrometry. J Chromatogr A 2009; 1216: 2045-62.
8. Liu XX, Wang L, Chen XQ, Deng XT, Cao Y, Wang Q. Simultaneous quantification of both triterpenoid and steroidal saponins in various Yunnan Baiyao preparations using HPLC-UV and HPLC-MS. J Sep Sci 2008; 31: 3834-46.
9. Z hang Q, Ye M. Chemical analysis of the Chinese herbal medicine Gan-Cao (licorice). J Chromatogr A 2009; 1216: 1954-69.
10. Wang X, Morris-Natschke SL, Lee KH. New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 2007; 27: 133-48.
11. Skou JC, Esmann M. The Na, K-ATPase. J Bioenerg Biomembr 1992; 24: 249-61.
12. Shinoda T, Ogawa H, Cornelius F, Toyoshima C. Crystal structure of the sodium-potassium pump at 2.4 Å resolution. Nature 2009; 459: 446-50.
13. Morth JP, Pedersen BP, Toustrup-Jensen MS, Sorensen TL, Petersen J, Andersen JP, et al. Crystal structure of the sodium-potassium pump. Nature 2007; 450: 1043-9.
14. +-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci USA 2009; 106: 13742-7.
15. O'Brien WJ, Lingrel JB, Wallick ET. Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate. Arch Biochem Biophys 1994; 310: 32-9.
16. +-ATPase activity in toad brain. Comp Biochem Physiol A Physiol 1997; 118: 599-606.
17. +)-ATPase alpha-subunit in Drosophila melanogaster. EMBO J 1989; 8: 193-202.
18. Rose AM, Valdes R Jr. Understanding the sodium pump and its relevance to disease. Clin Chem 1994; 40: 1674-85.
19. Gillis RA, Quest JA. The role of the nervous system in the cardiovascular effects of digitalis. Pharmacol Rev 1979; 31: 19-97.
20. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 1998; 275: F633-50.
21. Lingrel JB. Na,K-ATPase: isoform structure, function, and expression. J Bioenerg Biomembr 1992; 24: 263-70.
22. Lingrel JB. The physiological significance of the cardiotonic steroid/ ouabain-binding site of the Na,K-ATPase. Annu Rev Physiol 2010; 72: 395-412.
23. 2+ stores and cell responsiveness. Am J Physiol 1993; 264: C1367-87.
24. Xie Z, Xie J. The Na/K-ATPase-mediated signal transduction as a target for new drug development. Front Biosci 2005; 10: 3100-9.
25. +-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv 2003; 3: 157-68.
26. +-ATPase regulation. Fundam Clin Pharmacol 2008; 22: 615-21.
27. Schonfeld W, Weiland J, Lindig C, Masnyk M, Kabat MM, Kurek A, et al. The lead structure in cardiac glycosides is 5 beta, 14 betaandrostane- 3 beta 14-diol. Naunyn Schmiedebergs Arch Pharmacol 1985; 329: 414-26.
28. Melero CP, Medarde M, San Feliciano A. A short review on cardiotonic steroids and their aminoguanidine analogues. Molecules 2000; 5: 51-81.
29. Li-Saw-Hee FL, Lip GY. Digoxin revisited. QJM 1998; 91: 259-64.
30. 2+-ATPase in enriched nerve-ending plasma membranes. Brain Res 1982; 235: 387-92.
31. Blaustein MP. The interrelationship between sodium and calcium fluxes across cell membranes. Rev Physiol Biochem Pharmacol 1974; 70: 33-82.
32. Ferrandi M, Barassi P, Molinari I, Torielli L, Tripodi G, Minotti E, et al. Ouabain antagonists as antihypertensive agents. Curr Pharm Des 2005; 11: 3301-5.
33. Yang Z, Luo H, Wang H, Hou H. Preparative isolation of bufalin and cinobufagin from Chinese traditional medicine ChanSu. J Chromatogr Sci 2008; 46: 81-5.
34. Bick RJ, Poindexter BJ, Sweney RR, Dasgupta A. Effects of ChanSu, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blocking. Life Sci 2002; 72: 699-709.
35. Lee E, Kim S, Chung KC, Choo MK, Kim DH, Nam G, et al. 20(S)- ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. Eur J Pharmacol 2006; 536: 69-77.
36. Jia WW, Bu X, Philips D, Yan H, Liu G, Chen X, et al. Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy. Can J Physiol Pharmacol 2004; 82: 431-7.
37. Chen Y, Zhan E, Chen H, Duan X, Guo L. Saponins with low sugar chain from the leaves of Panax notoginseng (Burk) F H Chen. Zhong Yao Cai 2002; 25: 176-8.
38. Lee IK, Kim DH, Lee SY, Kim KR, Choi SU, Hong JK, et al. Triterpenoic acids of Prunella vulgaris var lilacina and their cytotoxic activities in vitro. Arch Pharm Res 2008; 31: 1578-83.
39. Ryu SY, Oak MH, Yoon SK, Cho DI, Yoo GS, Kim TS, et al. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med 2000; 66: 358-60.
40. Tan LL, Cai X, Hu ZH, Ni XL. Localization and dynamic change of saikosaponin in root of Bupleurum chinense. J Integr Plant Biol 2008; 50: 951-7.
41. +- ATPase inhibiting action. Yao Xue Xue Bao 1996; 31: 496-501.
42. Wang FS, Xu LX, Zhao YJ, Liu AR, Jin LZ, Zhang XQ. Determination of bile acids in bear gall drainage by thin layer chromatographic scanning. Yao Xue Xue Bao 1989; 24: 397-400.
43. Kurozumi K, Harano T, Yamasaki K, Ayaki Y. Studies on bile acids in bear bile. J Biochem 1973; 74: 489-95.
44. Liu Y, Chen W, Qiao C, Zhao N. Determination of sarsasapogenin in Anemarrhena asphodeloides Bunge by GC. Zhongguo Zhong Yao Za Zhi 1999; 24: 554-5, 75.
45. Fu WW, Hou WB, Dou DQ, Hua HM, Gui MH, Fu R, et al. Saponins of polygalacic acid type from Platycodon grandiflorum. Yao Xue Xue Bao 2006; 41: 358-60.
46. Z hang M, Zhang Y, Xie J. Simultaneous determination of jujuboside A, B and betulinic acid in semen Ziziphi spinosae by high performance liquid chromatography-evaporative light scattering detection. J Pharm Biomed Anal 2008; 48: 1467-70.
47. Hennell JR, Lee S, Khoo CS, Gray MJ, Bensoussan A. The determination of glycyrrhizic acid in Glycyrrhiza uralensis Fisch ex DC (Zhi Gan Cao) root and the dried aqueous extract by LC-DAD. J Pharm Biomed Anal 2008; 47: 494-500.
48. Sun ZR, Zhai MP, Wang WQ, Li YR. Effects of density on seedling growth and glycyrrhizinic acid content in Glycyrrhiza uralensis. Zhongguo Zhong Yao Za Zhi 2007; 32: 2222-6, 81. Chinese.
49. Xu Q, Ma X, Liang X. Determination of astragalosides in the roots of Astragalus spp using liquid chromatography tandem atmospheric pressure chemical ionization mass spectrometry. Phytochem Analysis 2007; 18: 419-27. (Pubitemid 47422798)
50. Lin HC, Ding HY, Wu YC. Two novel compounds from Paeonia suffructicosa. J Nat Prod 1998; 61: 343-6.
51. Zhu TT, Liang H, Zhao YY, Wang B. Isolation and structure identification of C-25 epimers of inokosterone from Achyranthes bidentata Blume. Yao Xue Xue Bao 2004; 39: 913-6. Chinese.
52. Hu T, Zhang X, Ma S, Cheng Y, Yao X. Chemical constituents from Corydalis yanhusuo. Zhongguo Zhong Yao Za Zhi 2009; 34: 1917-20. Chinese.
53. Z hang J, Jin Y, Liu Y, Xiao Y, Feng J, Xue X, et al. Purification of alkaloids from Corydalis yanhusuo W T Wang using preparative 2-D HPLC. J Sep Sci 2009; 32: 1401-6.
54. Z hang WB, Chen CX, Sim SM, Kwan CY. In vitro vasodilator mechanisms of the indole alkaloids rhynchophylline and isorhynchophylline, isolated from the hook of Uncaria rhynchophylla (Miquel). Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 232-8.
55. Shi JS, Yu JX, Chen XP, Xu RX. Pharmacological actions of Uncaria alkaloids, rhynchophylline and isorhynchophylline. Acta Pharmacol Sin 2003; 24: 97-101.
56. Nakazawa T, Banba K, Hata K, Nihei Y, Hoshikawa A, Ohsawa K. Metabolites of hirsuteine and hirsutine, the major indole alkaloids of Uncaria rhynchophylla, in rats. Biol Pharm Bull 2006; 29: 1671-7.
57. Horie S, Yano S, Aimi N, Sakai S, Watanabe K. Effects of hirsutine, an antihypertensive indole alkaloid from Uncaria rhynchophylla, on intracellular calcium in rat thoracic aorta. Life Sci 1992; 50: 491-8.
58. Ozaki Y. Vasodilative effects of indole alkaloids obtained from domestic plants, Uncaria rhynchophylla Miq and Amsonia elliptica Roem et Schult. Nippon Yakurigaku Zasshi 1990; 95: 47-54. Japanese.
59. Oh H, Mun YJ, Im SJ, Lee SY, Song HJ, Lee HS, et al. Cucurbitacins from Trichosanthes kirilowii as the inhibitory components on tyrosinase activity and melanin synthesis of B16/F10 melanoma cells. Planta Med 2002; 68: 832-3.
60. Takahashi N, Yoshida Y, Sugiura T, Matsuno K, Fujino A, Yamashita U. Cucurbitacin D isolated from Trichosanthes kirilowii induces apoptosis in human hepatocellular carcinoma cells in vitro. Int Immunopharmacol 2009; 9: 508-13.
61. Badria FA, Mikhaeil BR, Maatooq GT, Amer MM. Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood. Z Naturforsch C 2003; 58: 505-16.
62. Jayaprakasha GK, Mandadi KK, Poulose SM, Jadegoud Y, Nagana Gowda GA, Patil BS. Novel triterpenoid from Citrus aurantium L. possesses chemopreventive properties against human colon cancer cells. Bioorg Med Chem 2008; 16: 5939-51.
63. Z hang S. Chemical constituents of the Sparganium stoloniferum Buch.-Ham. Zhongguo Zhong Yao Za Zhi 1995; 20: 486-7. Chinese.
64. Z heng Y, Yang XW. Two new lanostane triterpenoids from Poria cocos. J Asian Nat Prod Res 2008; 10: 323-8.
65. +-ATPase. Acta Pharmacol Sin 2010; 31: 696-702.
66. Li XC, Yu C, Sun WK, Liu GY, Jia JY, Wang YP. Pharmacokinetics of magnesium lithospermate B after intravenous administration in beagle dogs. Acta Pharmacol Sin 2004; 25: 1402-7.
67. Shigematsu T, Tajima S, Nishikawa T, Murad S, Pinnell SR, Nishioka I. Inhibition of collagen hydroxylation by lithospermic acid magnesium salt, a novel compound isolated from Salviae miltiorrhizae Radix. Biochim Biophys Acta 1994; 1200: 79-83.
68. Lu Y, Foo LY. Polyphenolics of Salvia - a review. Phytochemistry 2002; 59: 117-40.
69. Wu XJ, Wang YP, Wang W, Sun WK, Xu YM, Xuan LJ. Free radical scavenging and inhibition of lipid peroxidation by magnesium lithospermate B. Acta Pharmacol Sin 2000; 21: 855-8.
70. Kasimu R, Tanaka K, Tezuka Y, Gong ZN, Li JX, Basnet P, et al. Comparative study of seventeen Salvia plants: aldose reductase inhibitory activity of water and MeOH extracts and liquid chromatographymass spectrometry (LC-MS) analysis of water extracts. Chem Pharm Bull 1998; 46: 500-4.
71. Yokozawa T, Chung HY, Dong E, Oura H. Confirmation that magnesium lithospermate B has a hydroxyl radical-scavenging action. Exp Toxicol Pathol 1995; 47: 341-4.
72. Yokozawa T, Lee TW, Oura H, Nonaka G, Nishioka I. Effect of magnesium lithospermate B in rats with sodium-induced hypertension and renal failure. Nephron 1992; 60: 460-5.
73. O K, Lynn EG, Vazhappilly R, Au-Yeung KK, Zhu DY, Siow YL. Magnesium tanshinoate B (MTB) inhibits low density lipoprotein oxidation. Life Sci 2001; 68: 903-12.
74. +-ATPase and neuroprotective effects against ischemic stroke. Acta Pharmacol Sin 2007; 28: 609-15.
75. 2+ level in SH-SY5Y cells. Acta Pharmacol Sin 2010; 31: 923-9.
76. Kulikov A, Eva A, Kirch U, Boldyrev A, Scheiner-Bobis G. Ouabain activates signaling pathways associated with cell death in human neuroblastoma. Biochim Biophys Acta 2007; 1768: 1691-702.
77. Z hu S, Zou K, Cai S, Meselhy MR, Komatsu K. Simultaneous determination of triterpene saponins in ginseng drugs by highperformance liquid chromatography. Chem Pharm Bull 2004; 52: 995-8.
78. Dan M, Su MM, Gao XF, Zhao T, Zhao AH, Xie GX, et al. Metabolite profiling of Panax notoginseng using UPLC-ESI-MS. Phytochemistry 2008; 69: 2237-44.
79. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 2004; 95: 153-7.
80. Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, et al. Modulating angiogenesis: the yin and the yang in ginseng. Circulation 2004; 110: 1219-25.
81. Lei XL, Chiou GC. Cardiovascular pharmacology of Panax notoginseng (Burk) F H Chen and Salvia miltiorrhiza. Am J Chin Med 1986; 14: 145-52.
82. Cicero AF, Vitale G, Savino G, Arletti R. Panax notoginseng (Burk) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet. Phytother Res 2003; 17: 174-8.
83. +-ATPase activity. Acta Pharmacol Sin 2009; 30: 61-9.
84. Nah SY, Kim DH, Rhim H. Ginsenosides: are any of them candidates for drugs acting on the central nervous system? Cns Drug Rev 2007; 13: 381-404.
85. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 2003; 31: 1065-71.
86. Shang HC, Gao XM, Guo LP. The optimization of different combinations and distributions between Danshen and Sanqi along with syn thetical information evaluation. Drug Evaluation 2005; 2: 209-11. Chinese.
87. Li XC, Yu C, Cai YB, Liu GY, Jia JY, Wang YP. Simultaneous determination of six phenolic constituents of danshen in human serum using liquid chromatography/tandem mass spectrometry. J Chromatogr B 2005; 820: 41-7.
88. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos 2003; 31: 1065-71.
89. Oian TX, Cai ZW, Wong RNS, Jiang ZH. Liquid chromatography mass spectrometric analysis of rat samples for in vivo metabolism and pharmacokinetic studies of ginsenoside Rh2. Rapid Commun Mass Sp 2005; 19: 3549-54.
90. Clausen T, Van Hardeveld C, Everts ME. Significance of cation transport in control of energy metabolism and thermogenesis. Physiol Rev 1991; 71: 733-74.
91. Friberg H, Wieloch T. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 2002; 84: 241-50.
92. Astrup J. Energy-requiring cell functions in the ischemic brain. Their critical supply and possible inhibition in protective therapy. J Neurosurg 1982; 56: 482-97.
93. Annunziato L, editor. New strategies in stroke intervention. New York: Springer; 2009.
94. Wang JK, Portbury S, Thomas MB, Barney S, Ricca DJ, Morris DL, et al. Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform. Proc Natl Acad Sci USA 2006; 103: 10461-6.
95. Z hang YG, Liu TP. Influences of ginsenosides Rb1 and Rg1 on reversible focal brain ischemia in rats. Zhongguo Yao Li Xue Bao 1996; 17: 44-8.
96. Tian J, Fu F, Geng M, Jiang Y, Yang J, Jiang W, et al. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neurosci Lett 2005; 374: 92-7. (Pubitemid 40092203)
97. Z hou XM, Cao YL, Dou DQ. Protective effect of ginsenoside Re against cerebral ischemia/reperfusion damage in rats. Biol Pharm Bull 2006; 29: 2502-5.
98. Yuan QL, Yang CX, Xu P, Gao XQ, Deng L, Chen P, et al. Neuroprotective effects of ginsenoside Rb1 on transient cerebral ischemia in rats. Brain Res 2007; 1167: 1-12.
99. Chen LM, Zhou XM, Cao YL, Hu WX. Neuroprotection of ginsenoside Re in cerebral ischemia-reperfusion injury in rats. J Asian Nat Prod Res 2008; 10: 439-45.
100. Cho SO, Ban JY, Kim JY, Ju HS, Lee IS, Song KS, et al. Anti-ischemic activities of Aralia cordata and its active component, oleanolic acid. Arch Pharm Res 2009; 32: 923-32.